[(breast cancer,refers to,BC,1.0), (Pregnancy-associated breast cancer,refers to,BC,1.0), (breast cancer,refers to,breast cancers,1.0), (Pregnancy-associated breast cancer,refers to,breast cancers,1.0)][(breast cancer,refers to,BC,1.0), (Pregnancy-associated breast cancer,refers to,BC,1.0), (breast cancer,refers to,breast cancers,1.0), (Pregnancy-associated breast cancer,refers to,breast cancers,1.0)][(breast cancer,refers to,BC,1.0), (Pregnancy-associated breast cancer,refers to,BC,1.0), (breast cancer,refers to,breast cancers,1.0), (Pregnancy-associated breast cancer,refers to,breast cancers,1.0)][(breast cancer,refers to,BC,1.0), (Pregnancy-associated breast cancer,refers to,BC,1.0), (breast cancer,refers to,breast cancers,1.0), (Pregnancy-associated breast cancer,refers to,breast cancers,1.0)]
[(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)][(PP-PABC,have,have scarcely distinguished,1.0), (PP-PABC,have,have distinguished from breast cancers,1.0), (environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed during pregnancy,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed during pregnancy,1.0), (inflammatory environment,may,may deleterious,1.0), (PP-PABC,have,have distinguished from breast cancers diagnosed,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers,1.0), (PP-PABC,have,have distinguished,1.0), (PP-PABC,have,have scarcely distinguished from breast cancers diagnosed,1.0)]
[(PP-PABC cases,have,infiltration,1.0), (PP-PABC cases,have,enhanced infiltration,1.0), (PP-PABC cases,have,immune infiltration,1.0), (PP-PABC cases,have,enhanced immune infiltration,1.0)][(PP-PABC cases,have,infiltration,1.0), (PP-PABC cases,have,enhanced infiltration,1.0), (PP-PABC cases,have,immune infiltration,1.0), (PP-PABC cases,have,enhanced immune infiltration,1.0)][(PP-PABC cases,have,infiltration,1.0), (PP-PABC cases,have,enhanced infiltration,1.0), (PP-PABC cases,have,immune infiltration,1.0), (PP-PABC cases,have,enhanced immune infiltration,1.0)][(PP-PABC cases,have,infiltration,1.0), (PP-PABC cases,have,enhanced infiltration,1.0), (PP-PABC cases,have,immune infiltration,1.0), (PP-PABC cases,have,enhanced immune infiltration,1.0)]
[(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)][(We,investigated,chemosensitivity,1.0), (We,investigated survival compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients,1.0), (We,investigated survival compared to,non-PABC matched BC patients,1.0), (We,investigated chemosensitivity compared to,non-PABC BC patients,1.0), (We,investigated chemosensitivity compared to,BC patients,1.0), (We,investigated survival compared to,non-PABC BC patients,1.0), (We,investigated infiltration compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated,1.0), (We,investigated chemosensitivity compared to,matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by neoadjuvant chemotherapy,1.0), (We,investigated infiltration compared to,non-PABC matched BC patients,1.0), (We,investigated infiltration compared to,non-PABC BC patients,1.0), (We,investigated,infiltration,1.0), (We,investigated,immune infiltration,1.0), (We,investigated chemosensitivity compared to,non-PABC matched BC patients,1.0), (We,investigated,chemosensitivity of PP-PABC patients treated by chemotherapy,1.0), (We,investigated,survival,1.0), (We,investigated infiltration compared to,BC patients,1.0), (We,investigated survival compared to,BC patients,1.0)]
[(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)][(We,identified,PP-PABC cases among cohort of 1199 invasive BC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC,1.0), (We,identified,PP-PABC cases among cohort treated,1.0), (We,identified,PP-PABC cases among cohort treated with NAC,1.0), (We,identified,PP-PABC cases,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated,1.0), (We,identified,PP-PABC cases among cohort,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 invasive BC treated with NAC,1.0), (We,identified,PP-PABC cases among cohort of 1199 BC treated,1.0)]
[(PP-PABC case,was,matched,1.0), (PP-PABC case,was matched with,3 non-PABC controls,1.0), (PP-PABC case,was matched with,3 controls,1.0), (PP-PABC case,was matched according to,age,1.0)][(PP-PABC case,was,matched,1.0), (PP-PABC case,was matched with,3 non-PABC controls,1.0), (PP-PABC case,was matched with,3 controls,1.0), (PP-PABC case,was matched according to,age,1.0)][(PP-PABC case,was,matched,1.0), (PP-PABC case,was matched with,3 non-PABC controls,1.0), (PP-PABC case,was matched with,3 controls,1.0), (PP-PABC case,was matched according to,age,1.0)][(PP-PABC case,was,matched,1.0), (PP-PABC case,was matched with,3 non-PABC controls,1.0), (PP-PABC case,was matched with,3 controls,1.0), (PP-PABC case,was matched according to,age,1.0)]
[(Microbiopsy specimens,were,evaluated for stromal lymphocyte infiltration,1.0), (Microbiopsy specimens,were,evaluated for lymphocyte infiltration,1.0), (Microbiopsy specimens,were,evaluated,1.0)][(Microbiopsy specimens,were,evaluated for stromal lymphocyte infiltration,1.0), (Microbiopsy specimens,were,evaluated for lymphocyte infiltration,1.0), (Microbiopsy specimens,were,evaluated,1.0)][(Microbiopsy specimens,were,evaluated for stromal lymphocyte infiltration,1.0), (Microbiopsy specimens,were,evaluated for lymphocyte infiltration,1.0), (Microbiopsy specimens,were,evaluated,1.0)]
[(Association,was,assessed,1.0), (Association,is with,pathological complete response,1.0), (Association,was assessed by,univariate analyses,1.0), (Association,was assessed by,analyses,1.0)][(Association,was,assessed,1.0), (Association,is with,pathological complete response,1.0), (Association,was assessed by,univariate analyses,1.0), (Association,was assessed by,analyses,1.0)][(Association,was,assessed,1.0), (Association,is with,pathological complete response,1.0), (Association,was assessed by,univariate analyses,1.0), (Association,was assessed by,analyses,1.0)][(Association,was,assessed,1.0), (Association,is with,pathological complete response,1.0), (Association,was assessed by,univariate analyses,1.0), (Association,was assessed by,analyses,1.0)]
[(Our final population study,was,composed,1.0), (Our population study,was composed of,116 patients,1.0), (Our final population study,was composed of,116 patients,1.0), (Our population study,was,composed,1.0)][(Our final population study,was,composed,1.0), (Our population study,was composed of,116 patients,1.0), (Our final population study,was composed of,116 patients,1.0), (Our population study,was,composed,1.0)][(Our final population study,was,composed,1.0), (Our population study,was composed of,116 patients,1.0), (Our final population study,was composed of,116 patients,1.0), (Our population study,was,composed,1.0)][(Our final population study,was,composed,1.0), (Our population study,was composed of,116 patients,1.0), (Our final population study,was composed of,116 patients,1.0), (Our population study,was,composed,1.0)]

[(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)][(post-NAC immune infiltration,were comparable After,NAC,1.0), (infiltration,were,comparable,1.0), (infiltration,were comparable After,NAC,1.0), (p,=,0.17,0.668093085850429), (post-NAC infiltration,were comparable After,NAC,1.0), (immune infiltration,were comparable After,NAC,1.0), (immune infiltration,were,comparable,1.0), (post-NAC infiltration,were,comparable,1.0), (pCR rates,were,comparable,1.0), (post-NAC immune infiltration,were,comparable,1.0), (pCR rates,were,After NAC comparable,1.0), (p,=,0.64,0.7173543785831931), (pCR rates,were comparable After,NAC,1.0)]
[(results,were found after,stratification by subtype,1.0), (results,were,found,1.0), (Similar results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification by subtype,1.0), (results,were found after,stratification,1.0), (Similar results,were,found,1.0), (results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification,1.0)][(results,were found after,stratification by subtype,1.0), (results,were,found,1.0), (Similar results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification by subtype,1.0), (results,were found after,stratification,1.0), (Similar results,were,found,1.0), (results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification,1.0)][(results,were found after,stratification by subtype,1.0), (results,were,found,1.0), (Similar results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification by subtype,1.0), (results,were found after,stratification,1.0), (Similar results,were,found,1.0), (results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification,1.0)][(results,were found after,stratification by subtype,1.0), (results,were,found,1.0), (Similar results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification by subtype,1.0), (results,were found after,stratification,1.0), (Similar results,were,found,1.0), (results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification,1.0)][(results,were found after,stratification by subtype,1.0), (results,were,found,1.0), (Similar results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification by subtype,1.0), (results,were found after,stratification,1.0), (Similar results,were,found,1.0), (results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification,1.0)][(results,were found after,stratification by subtype,1.0), (results,were,found,1.0), (Similar results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification by subtype,1.0), (results,were found after,stratification,1.0), (Similar results,were,found,1.0), (results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification,1.0)][(results,were found after,stratification by subtype,1.0), (results,were,found,1.0), (Similar results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification by subtype,1.0), (results,were found after,stratification,1.0), (Similar results,were,found,1.0), (results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification,1.0)][(results,were found after,stratification by subtype,1.0), (results,were,found,1.0), (Similar results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification by subtype,1.0), (results,were found after,stratification,1.0), (Similar results,were,found,1.0), (results,were found after,stratification by pathological subtype,1.0), (Similar results,were found after,stratification,1.0)]
[(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)][(We,observed,patterns in terms of chemosensitivity,1.0), (We,observed,patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,patterns in terms,1.0), (We,observed,patterns between postpartum PABC in terms,1.0), (We,observed,patterns between PABC in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms,1.0), (We,observed,similar patterns,1.0), (We,observed,patterns between PABC,1.0), (similar patterns,is in,terms of chemosensitivity,1.0), (We,observed,similar patterns between PABC in terms,1.0), (We,observed,patterns between postpartum PABC,1.0), (We,observed,similar patterns in terms of chemosensitivity,1.0), (We,observed,patterns between PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns in terms,1.0), (We,observed,similar patterns between postpartum PABC in terms of chemosensitivity,1.0), (We,observed,similar patterns between postpartum PABC,1.0), (We,observed,patterns,1.0), (We,observed,similar patterns between PABC,1.0), (We,observed,similar patterns between PABC in terms of chemosensitivity,1.0)]
[(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)][(PP-PABC,receive,same standard,1.0), (PP-PABC,receive,same standard of care treatment,1.0), (PP-PABC,receive standard as,patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard of care treatment,1.0), (PP-PABC,receive standard as,other patients including chemotherapy,1.0), (PP-PABC,receive standard as,patients including chemotherapy,1.0), (PP-PABC,receive standard as,other patients,1.0), (PP-PABC,standard of,care treatment,0.7742545778295105), (Our results,enhance,idea,1.0), (PP-PABC,receive standard as,other patients including neoadjuvant chemotherapy,1.0), (PP-PABC,receive,standard,1.0), (PP-PABC,same standard of,care treatment,0.7742545778295105), (PP-PABC,receive standard as,patients,1.0)]
